Content about Millennium Development Goals

November 14, 2013

Antiretroviral drugs have allowed people with HIV to live normal life spans, but because of this, they also are susceptible to many new health complications, according to care guidelines released Thursday by the Infectious Diseases Society of America.

ARLINGTON, Va. — Antiretroviral drugs have allowed people with HIV to live normal life spans, but because of this, they also are susceptible to many new health complications, according to care guidelines released Thursday by the Infectious Diseases Society of America.

July 18, 2013

Almost twice as many drugs for neglected diseases have received regulatory approval around the world over the past few years compared with the beginning of the last decade, according to a new study.

BOSTON — Almost twice as many drugs for neglected diseases have received regulatory approval around the world over the past few years compared with the beginning of the last decade, according to a new study.

June 17, 2013

Reckitt Benckiser, whose portfolio includes such brands as Clearasil, Mucinex and Lysol, is partnering with Save the Children to help drastically lower the global death rate of children younger than 5 years from diarrhea, a preventable illness, by 2020.

PARSIPANNY, N.J. — Reckitt Benckiser, whose portfolio includes such brands as Clearasil, Mucinex and Lysol, is partnering with Save the Children to help drastically lower the global death rate of children younger than 5 years from diarrhea, a preventable illness, by 2020.

The "Healthier kids, Happier homes" global partnership, with an initial funding of $35.5 million, will combine RB's expertise in hygiene and health, innovative technology and consumer communication capabilities with Save the Children's expertise in delivering life-saving treatment.

November 21, 2011

A subsidiary of Aceto Corp. has launched two generic drugs for treating infectious diseases, the company said Monday.

PORT WASHINGTON, N.Y. — A subsidiary of Aceto Corp. has launched two generic drugs for treating infectious diseases, the company said Monday.

Aceto said its Rising Pharmaceuticals subsidiary launched flucytosine capsules, a version of Valeant Pharmaceuticals International's Ancobon, used to treat serious infections; and chloroquine phosphate tablets, a generic version of Sanofi's malaria drug Aralen. The drugs' branded versions had sales of $20 million during the 12-month period ended in June, Aceto said.